NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
Chemical name: | Microbubbles conjugated with cyclo(CGGRRLGGC) | |
Abbreviated name: | MBRRL | |
Synonym: | ||
Agent Category: | Peptide | |
Target: | Unknown | |
Target Category: | Receptor binding to tumor-derived endothelial cells | |
Method of detection: | Ultrasound (US) | |
Source of signal: | Microbubbles | |
Activation: | No | |
Studies: |
| No structure is available in PubChem. |
Background
[PubMed]
Ultrasound is the most widely used imaging modality (1), and its role in non-invasive molecular imaging is expanding with ligand-carrying microbubbles (2). Microbubbles are spherical cavities filled with a gas encapsulated in a shell. The shells are made of phospholipids, a surfactant, denatured human serum albumin, or a synthetic polymer. Ligands and antibodies can be incorporated into the shell surface of microbubbles, which are usually 2–8 μm in diameter. Microbubbles provide a strongly reflective interface and resonate to ultrasound waves, and they are used as ultrasound contrast agents in imaging of inflammation, angiogenesis, intravascular thrombus, and tumors (3-5). They also have the potential to be used for drug and gene delivery (6).
Endothelial cells are important cells in inflammatory responses (7, 8). Bacterial lipopolysaccharide, virus, inflammation, and tissue injury increase tumor necrosis factor α, interleukin-1, and other cytokine and chemokine secretion. Leukocyte emigration from blood is dependent on the leukocytes rolling along endothelial cell surfaces and subsequently adhering to endothelial cell surfaces. Inflammatory mediators and cytokines induce chemokine secretion from endothelial cells and other vascular cells and increase their expression of cell surface adhesion molecules such as intracellular adhesion molecule-1, vascular cell adhesion molecule-1, integrins, and selectins. Chemokines are chemotactic to leukocytes at sites of inflammation and tissue injury (9). Angiogenesis is a process of development and growth of new blood vessels from pre-existing vessels. Tumor growth depends on the formation of new blood vessels from angiogenesis. Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) enhance angiogenesis. Expression of VEGF receptors is higher on the cell surface of tumor-derived endothelial cells than on the cell surface of normal endothelial cells.
Microbubbles conjugated to peptides or to antibodies against integrins, cell adhesion molecules, and VEGF receptors have previously been studied for the non-invasive assessment and imaging of angiogenesis (10-13). A peptide specific to tumor vasculature and containing Arg-Arg-Leu (RRL) was identified by screening a peptide display library panned against tumor cells derived from SCC-VII murine squamous cell carcinomas (14). Weller et al. (12) studied ultrasonic imaging of tumor vasculature using microbubbles conjugated with biotinylated c(CGGRRLGGC) (MBRRL) in mice bearing human tumor xenografts.
Synthesis
[PubMed]
For targeted microbubbles, Weller et al. (12) prepared biotinylated microbubbles by sonication of an aqueous dispersion of decafluorobutane gas, phosphatidylcholine, polyethylene glycol-stearate, and phosphatidylethanolamine-biotin in a 2:1:1 ratio by weight. Microbubbles were combined with streptavidin, washed, and conjugated with MBRRL or control peptide c(CGGGGGGGC) (MBcontrol). The microbubbles are 3.2 ± 1.0 μm in diameter. The peptide/microbubble ratio was estimated with flow cytometry to be ~60,000 (10).
In Vitro Studies: Testing in Cells and Tissues
[PubMed]
Weller et al. (12) reported that MBRRL or MBcontrol (3.33 × 106/ml) perfused through the flow chamber coated with endothelial cells at a wall shear rate of 100 s-1 for 3 min. There was a significantly (P < 0.01) greater number of MBRRL attached to tumor-activated endothelial cells (2.4 ± 0.6 microbubbles/cell) than to normal endothelial cells (0.8 ± 0.1 microbubbles/cell). MBcontrol attachment to both activated and normal endothelial cells was minimal (0.3–0.4 microbubbles/cell).
Animal Studies
Rodents
[PubMed]
Weller et al. (12) performed ultrasound assessment of MBRRL binding in five mice bearing Clone C tumors (transfected with bFGF), six mice bearing PC3 tumors, and six normal mice. There were intense acoustic signals in both tumors at 2 min after MBRRL injection compared with mild contrast in tumors injected with MBcontrol. There was little difference in myocardial signal intensity between MBRRL and MBcontrol in normal mice. The mean video intensity for normal myocardium was 0.5 ± 1 units, whereas the mean video intensity for the tumors was 5 ± 1 units (P = 0.0001). Postmortem histology demonstrated that the density of RRL binding was concentrated at the tumor periphery. No blocking studies or other studies to validate the mechanism were reported.
NIH Support
R01 HL-58865
References
- 1.
- Wells P.N. Physics and engineering: milestones in medicine. Med Eng Phys. 2001; 23 (3):147–53. [PubMed: 11410379]
- PubMedLinks to PubMed
- Review Microbubbles coated with antibody to intracellular adhesion molecule-1.[Molecular Imaging and Contrast...]Review Microbubbles coated with antibody to intracellular adhesion molecule-1.Leung K. Molecular Imaging and Contrast Agent Database (MICAD). 2004
- Review Microbubbles coated with antibody to mucosal addressin cellular adhesion molecule-1.[Molecular Imaging and Contrast...]Review Microbubbles coated with antibody to mucosal addressin cellular adhesion molecule-1.Leung K. Molecular Imaging and Contrast Agent Database (MICAD). 2004
- Review Magnetic microbubbles conjugated with anti-vascular cell adhesion molecule-1 monoclonal antibody 429.[Molecular Imaging and Contrast...]Review Magnetic microbubbles conjugated with anti-vascular cell adhesion molecule-1 monoclonal antibody 429.Leung K. Molecular Imaging and Contrast Agent Database (MICAD). 2004
- Review Microbubbles conjugated with anti-vascular cell adhesion molecule-1 nanobody cAbVCAM1-5.[Molecular Imaging and Contrast...]Review Microbubbles conjugated with anti-vascular cell adhesion molecule-1 nanobody cAbVCAM1-5.Leung K. Molecular Imaging and Contrast Agent Database (MICAD). 2004
- Review Microbubbles coated with anti-P-selectin antibody RB40.34.[Molecular Imaging and Contrast...]Review Microbubbles coated with anti-P-selectin antibody RB40.34.Leung K. Molecular Imaging and Contrast Agent Database (MICAD). 2004
- Microbubbles conjugated with cyclo(CGGRRLGGC) - Molecular Imaging and Contrast A...Microbubbles conjugated with cyclo(CGGRRLGGC) - Molecular Imaging and Contrast Agent Database (MICAD)
- Microbubbles conjugated with anti-vascular cell adhesion molecule-1 nanobody cAb...Microbubbles conjugated with anti-vascular cell adhesion molecule-1 nanobody cAbVCAM1-5 - Molecular Imaging and Contrast Agent Database (MICAD)
- Microbubbles conjugated with anti-matrix metalloproteinase 2 mouse monoclonal an...Microbubbles conjugated with anti-matrix metalloproteinase 2 mouse monoclonal antibody sc-13595 - Molecular Imaging and Contrast Agent Database (MICAD)
- Microbubbles coated with biotinylated rabbit anti-mouse αVβ3 integrin monoclonal...Microbubbles coated with biotinylated rabbit anti-mouse αVβ3 integrin monoclonal antibody - Molecular Imaging and Contrast Agent Database (MICAD)
- Microbubbles coated with biotinylated rabbit anti-mouse vascular endothelial gro...Microbubbles coated with biotinylated rabbit anti-mouse vascular endothelial growth factor receptor 2 (VEGFR-2) monoclonal antibody - Molecular Imaging and Contrast Agent Database (MICAD)
Your browsing activity is empty.
Activity recording is turned off.
See more...